NEW YORK (GenomeWeb News) – The University of Cambridge, Genomics England, and Illumina plan to sequence 10,000 whole genomes of children and adults with rare genetic diseases over three years, the organizations said today.

Under the study, called the Rare Diseases Genomes Project, researchers at the University of Cambridge will work with a team at Illumina led by Chief Scientist David Bentley to develop a workflow and processes for bringing routine clinical whole-genome sequencing to patients. Illumina will contribute the sequencing data using its own technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.